Cargando…
Successful chelation in beta-thalassemia major in the 21(st) century
This century has seen a revolution the management of beta-thalassemia major. Over a 12-year period to 2016, we aimed to analyze the benefits of such advances. In 209 patients, independent of the chelation regimen, ferritin, cardiac T2* and liver iron concentration changes were evaluated. We defined...
Autores principales: | Fragodimitri, Christina, Schiza, Vasiliki, Giakoumis, Anastasios, Drakaki, Kalliopi, Salichou, Anastasia, Karampatsos, Fotis, Yousef, Jacqueline, Karageorga, Markissia, Berdoukas, Vasili, Aessopos, Athanasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578721/ https://www.ncbi.nlm.nih.gov/pubmed/37832083 http://dx.doi.org/10.1097/MD.0000000000035455 |
Ejemplares similares
-
Cardiac Function and Iron Chelation in Thalassemia Major and Intermedia: a Review of the Underlying Pathophysiology and Approach to Chelation Management
por: Aessopos, Athanasios, et al.
Publicado: (2009) -
Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion dependent thalassemia major (TM)
por: Giakoumis, Anastasios, et al.
Publicado: (2007) -
Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
por: Smith, Gillian C, et al.
Publicado: (2011) -
Molecular genetics of β-thalassemia: A narrative review
por: Jaing, Tang-Her, et al.
Publicado: (2021) -
Molecular characterization of hemoglobinopathies and thalassemias in Northern Guangdong Province, China
por: Ma, Zhanzhong, et al.
Publicado: (2021)